Citadel Advisors
OPT

Citadel Advisors’s Opthea Limited American Depositary Shares OPT Stock Holding History

Citadel Advisors’s Portfolio OPT Stock Details OPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,998
Closed -$79K – 16069
2024
Q4 		$79K Buy
+19,998
New +$79.7K ﹤0.01% 11805

Other funds holding OPT

HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
TLCM
Twin Lakes Capital Management Redwood Shores, California $262M AUM 60.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EP Wealth Advisors
EP Wealth Advisors Torrance, California $26.2B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors's OPT Position: Q1 2025 in Review

Citadel Advisors sold out of Opthea Limited American Depositary Shares (OPT) in Q1 2025, closing a stake of 19,998 shares — an estimated $79K sold.

Citadel Advisors first reported a position in OPT in Q4 2024 and held it in 1 quarter. The position peaked at $79K in Q4 2024. 9 funds tracked by Wall St. Rank hold OPT as of Q1 2025.

  • Citadel Advisors reported no remaining Opthea Limited American Depositary Shares position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 19,998 Opthea Limited American Depositary Shares shares in Q1 2025, an estimated $79K.
  • Citadel Advisors first reported a position in Opthea Limited American Depositary Shares in Q4 2024 and held it in 1 quarter.
  • Citadel Advisors's Opthea Limited American Depositary Shares position peaked at $79K in Q4 2024.
  • 9 funds tracked by Wall St. Rank held Opthea Limited American Depositary Shares as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.